enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Phosphofructokinase 1 - Wikipedia

    en.wikipedia.org/wiki/Phosphofructokinase_1

    Phosphofructokinase-1 (PFK-1) is one of the most important regulatory enzymes (EC 2.7.1.11) of glycolysis. It is an allosteric enzyme made of 4 subunits and controlled by many activators and inhibitors. PFK-1 catalyzes the important "committed" step of glycolysis, the conversion of fructose 6-phosphate and ATP to fructose 1,6-bisphosphate and ADP.

  3. Phosphofructokinase - Wikipedia

    en.wikipedia.org/wiki/Phosphofructokinase

    The enzyme-catalysed transfer of a phosphoryl group from ATP is an important reaction in a wide variety of biological processes. [1] Phosphofructokinase catalyses the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, a key regulatory step in the glycolytic pathway. [2][3] It is allosterically inhibited by ATP and ...

  4. 1-phosphofructokinase - Wikipedia

    en.wikipedia.org/wiki/1-phosphofructokinase

    1-phosphofructokinase. In enzymology, 1-phosphofructokinase (EC 2.7.1.56) is an enzyme that catalyzes the chemical reaction. Thus, the two substrates of this enzyme are ATP and D-fructose 1-phosphate, whereas its two products are ADP and D-fructose 1,6-bisphosphate. The enzyme was first described and characterized in the 1960s. [1][2]

  5. TP53-inducible glycolysis and apoptosis regulator - Wikipedia

    en.wikipedia.org/wiki/TP53-inducible_glycolysis...

    Phosphofructokinase-1 catalyses the addition of a phosphate to F-6-P to form Fructose-1,6-bisphosphate (F-1,6-BP). This is an essential step in the glycolysis pathway, which forms the first part of aerobic respiration in mammals. F-2,6-BP also binds to and decreases the activity of fructose-1,6-bisphosphatase. [9]

  6. Phosphofructokinase deficiency - Wikipedia

    en.wikipedia.org/wiki/Phosphofructokinase_deficiency

    Phosphofructokinase deficiency; Other names: Glycogen storage disease type VII or Tarui's disease [1] [2] A rendering of the human muscular form of phosphofructokinase. Mutations in the production of this enzyme are the cause of Tarui's disease. [3] The symmetry of the enzyme is a result of its tetrameric structure. Specialty: Endocrinology ...

  7. Pasteur effect - Wikipedia

    en.wikipedia.org/wiki/Pasteur_effect

    Pasteur effect. The Pasteur effect describes how available oxygen inhibits ethanol fermentation, driving yeast to switch toward aerobic respiration for increased generation of the energy carrier adenosine triphosphate (ATP). [1] More generally, in the medical literature, the Pasteur effect refers to how the cellular presence of oxygen causes in ...

  8. Fructose 2,6-bisphosphate - Wikipedia

    en.wikipedia.org/wiki/Fructose_2,6-bisphosphate

    Fructose 2,6-bisphosphate, abbreviated Fru-2,6-P2, is a metabolite that allosterically affects the activity of the enzymes phosphofructokinase 1 (PFK-1) and fructose 1,6-bisphosphatase (FBPase-1) to regulate glycolysis and gluconeogenesis. [1] Fru-2,6- P2 itself is synthesized and broken down in either direction by the integrated bifunctional ...

  9. PFKM - Wikipedia

    en.wikipedia.org/wiki/PFKM

    PFKM. 6-phosphofructokinase, muscle type is an enzyme that in humans is encoded by the PFKM gene on chromosome 12. Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to ...